The US Department of Health and Human Services (HHS) has announced the appointment of four permanent senior leaders to critical…
Read More
New York Times-lauded Medvi is marketing QUAD, a four-drug ED cocktail with a Parkinson’s drug component
The Unapproved QUAD Cocktail: A Closer Look at its Composition QUAD is a compounded sublingual dose product marketed by MEDVi…
Read More
FDA Approves Four Groundbreaking Cancer Drugs in May, Offering New Hope for Hematological and Solid Tumors
The U.S. Food and Drug Administration (FDA) has authorized four significant new cancer drugs in May 2026, marking a pivotal…
Read More
New York Times-lauded Medvi is marketing QUAD, a four-drug ED cocktail with a Parkinson’s drug component
In the wake of The New York Times’ April 2 profile, which painted MEDVi CEO Matthew Gallagher as a "vibe-coded…
Read More
Doherty Institute Researchers Unveil Groundbreaking Assay Identifying Four STIs and Antibiotic Resistance with Unprecedented Speed and Precision
Researchers at the Peter Doherty Institute for Infection and Immunity in Australia have announced a significant breakthrough in diagnostic medicine,…
Read More
New York Times-lauded Medvi is marketing QUAD, a four-drug ED cocktail with a Parkinson’s drug component
QUAD is marketed by MEDVi as a sublingual, four-drug cocktail for erectile dysfunction, combining three well-known PDE5 inhibitors—sildenafil, tadalafil, and…
Read More
Doherty Institute researchers unveil an assay that identifies four STIs and antibiotic resistance in under an hour with up to 100% precision.
Researchers at the prestigious Peter Doherty Institute for Infection and Immunity in Melbourne, Australia, have announced a groundbreaking advancement in…
Read More
New York Times-lauded Medvi is marketing QUAD, a four-drug ED cocktail with a Parkinson’s drug component
The digital health company MEDVi, recently spotlighted in an April 2 New York Times profile that depicted CEO Matthew Gallagher…
Read More
Doherty Institute researchers unveil an assay that identifies four STIs and antibiotic resistance in under an hour with up to 100% precision.
Researchers at the prestigious Peter Doherty Institute for Infection and Immunity in Melbourne, Australia, have announced a groundbreaking advancement in…
Read More
Doherty Institute Researchers Unveil Groundbreaking Assay for Rapid, Precise Detection of Four STIs and Antibiotic Resistance
Researchers at the Peter Doherty Institute for Infection and Immunity in Australia have developed a portable, point-of-care diagnostic tool capable…
Read More
